(MedPage Today) — Weight regain after the withdrawal of tirzepatide (Zepbound) may wipe out many of the cardiometabolic gains made during weight loss, a post-hoc analysis of the SURMOUNT-4 trial indicated.
Among 308 participants with obesity…
Source link : https://www.medpagetoday.com/endocrinology/obesity/118686
Author :
Publish date : 2025-11-24 21:44:00
Copyright for syndicated content belongs to the linked Source.
